Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Mesa Laboratories, Inc. (MLAB : NSDQ)

• Company Description    MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. Number of Employees: 506

• Price / Volume Information    Yesterday's Closing Price: $217.98 Daily Weekly Monthly 20 Day Moving Average: 31,675 shares Shares Outstanding: 5.25 (millions) Market Capitalization: $1,143.51 (millions) Beta: 0.54 52 Week High: $333.42 52 Week Low: $210.11 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -12.81% -4.82% 12 Week -14.14% -7.21% Year To Date -33.56% -21.31%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 12100 W 6TH AVE - LAKEWOOD,CO 80228 USA ph: 303-987-8000 fax: 303-987-8989 investorrelations@mesalabs.com http://www.mesalabs.com

• General Corporate Information    Officers Gary M. Owens - Chief Executive Officer; President and Director John J. Sullivan - Chairman of the Board of Directors John V. Sakys - Chief Financial Officer John B Schmieder - Director Jennifer S. Alltoft - Director Peer Information Mesa Laboratories, Inc. (ABMD) Mesa Laboratories, Inc. (DMDS) Mesa Laboratories, Inc. (CPWY.) Mesa Laboratories, Inc. (EQUR) Mesa Laboratories, Inc. (ECIA) Mesa Laboratories, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 59064R109 SIC: 3823 Fiscal Year Fiscal Year End: March Last Reported Quarter: 12/01/21 Next Expected EPS Date: 06/07/22 Share - Related Items Shares Outstanding: 5.25 Most Recent Split Date: (:1) Beta: 0.54 Market Capitalization: $1,143.51 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.29% Current Fiscal Quarter EPS Consensus Estimate: $1.08 Indicated Annual Dividend: $0.64 Current Fiscal Year EPS Consensus Estimate: $7.02 Payout Ratio: 0.14 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: -0.01 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 02/25/2022 - $0.16 Next EPS Report Date: 06/07/22

• Fundamental Ratios P/E Current FY Estimate: 31.05 Trailing 12 Months: 46.58 PEG Ratio: - Price Ratios Price/Book: 2.89 Price/Cash Flow: 22.60 Price / Sales: 7.00 EPS Growth vs. Year Ago Period: -6.58% vs. Previous Quarter: -52.35% Sales Growth vs. Year Ago Period: 60.06% vs. Previous Quarter: 52.61% ROE 03/31/22 - - 12/31/21 - 6.23 09/30/21 - 6.17 ROA 03/31/22 - - 12/31/21 - 3.92 09/30/21 - 4.08 Current Ratio 03/31/22 - - 12/31/21 - 2.59 09/30/21 - 11.13 Quick Ratio 03/31/22 - - 12/31/21 - 2.08 09/30/21 - 10.71 Operating Margin 03/31/22 - - 12/31/21 - 15.26 09/30/21 - 17.45 Net Margin 03/31/22 - - 12/31/21 - 4.64 09/30/21 - 3.56 Pre-Tax Margin 03/31/22 - - 12/31/21 - 5.21 09/30/21 - 3.59 Book Value 03/31/22 - - 12/31/21 - 75.55 09/30/21 - 76.44 Inventory Turnover 03/31/22 - - 12/31/21 - 4.38 09/30/21 - 4.40 Debt-to-Equity 03/31/22 - - 12/31/21 - 0.58 09/30/21 - 0.42 Debt-to-Capital 03/31/22 - - 12/31/21 - 36.63 09/30/21 - 29.72

Powered by Zacks Investment Research ©